Another molecule in the IGF signaling pathway, ST14, a transmembrane serine protease, has been implicated in metastatic cancer, which utilizes a molecular program reminiscent of embryonic EMT [72]. This evidence concerns the gene IGF1 and metastatic malignant neoplasm.